Compare STRT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRT | ORGO |
|---|---|---|
| Founded | 1908 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.3M | 348.6M |
| IPO Year | 1996 | 2016 |
| Metric | STRT | ORGO |
|---|---|---|
| Price | $74.48 | $2.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 34.0K | ★ 686.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.53 | ★ 1600.00 |
| EPS | ★ 3.26 | 0.15 |
| Revenue | $439,195,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $4.22 | N/A |
| Revenue Next Year | $2.04 | $17.84 |
| P/E Ratio | $22.59 | ★ $16.00 |
| Revenue Growth | 5.24 | ★ 17.04 |
| 52 Week Low | $31.71 | $2.39 |
| 52 Week High | $92.50 | $7.08 |
| Indicator | STRT | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 33.84 | 19.54 |
| Support Level | $72.01 | N/A |
| Resistance Level | $84.14 | $5.08 |
| Average True Range (ATR) | 3.55 | 0.20 |
| MACD | -1.20 | -0.03 |
| Stochastic Oscillator | 5.74 | 0.48 |
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.